Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer
Clinical trial NCT00522665 · COMPLETED
Trial details
- NCT number
- NCT00522665
- Sponsor
- Hoosier Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2011-05-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.